Posts

The Importance of Taking Care of the Caregiver

GCC March Blog Image 2

For cancer patients, receiving a diagnosis is often a time of fear, stress and trauma. The fear of the unknown, treatment processes and the disruption to life’s routines can be overwhelming. The experience is life altering, not only for the patient but also for family and close friends. For certain, life will never be the same for all involved.

While the initial focus and turmoil centers around the patient, the emotional impact on those who step up to be caregivers are too often overlooked. The dedication of time and resources to drive the patient to their frequent treatments, look in on them to monitor the therapies’ progress and extend their understanding and emotional support can be significant. Truly, no one fights cancer alone.

Being a caregiver can be very challenging. Many caregivers are close family and friends who are impacted equally by the diagnosis. The experience often creates a new role and unprecedented change for friend and family relationships. Feelings of confusion and stress accompany the changes in daily routines for all involved. Once relatively equal give and take relationships are now tipped more toward the cancer patient. Over an extended period of time this unbalanced set of emotional and physical needs can leave a caregiver feeling depressed and overwhelmed.

Educating yourself about the patient’s disease and the therapies and treatments they will be experiencing can help a caregiver cope with the challenges that lie ahead.  “I remember it was important for me to understand the kind of breast cancer my wife (Viola) had,” says Nathan Jones.  “It was triple-negative, so it was very aggressive. Because I had learned everything I could about Viola’s cancer, I understood that even though she wasn’t sick in bed or even in pain, her cancer was going to grow fast and we needed to be proactive.” Knowing and understanding is nearly always better and less stressful.

Many caregivers admit, usually in hindsight, that they took on too much. Accepting help from others and sharing feelings of being over taxed is never easy, but having someone assist with routine chores like cooking, cleaning, shopping and yardwork can relieve the pressure on a caregiver’s time, energy and feelings of inadequacy.  Focusing on your own needs, hopes, and desires can give you the strength to meet new challenges and understand conflicting feelings.

Support groups dedicated to caring for the caregiver are widely available in small group settings or online. Studies show that talking with others about what you’re dealing with is very important. It’s especially helpful when you feel overwhelmed or want to say things that you can’t say to your loved one with cancer.

Keeping a journal has been shown to help relieve negative feelings and stress. Share your journey with others who show interest.  Ken Owenson, caregiver and husband to a breast cancer patient says, “We find a lot of strength from sitting down with patients and giving them a place to vent some of their anxiety, and it also gives us a chance to clear our minds, too.  It’s not good to internalize it because that just makes it worse.”

For more information on how you can better manage your caregiver journey, contact the cancer care specialists at http://gettysburgcancercenter.com/contact-us/.

Understanding the Nexus of Aging and the Increase in Cancer Risk

GCC March Blog Image 1 (640x427)

As Americas’ Greatest Generation continue to age studies are revealing that with the increase in the age of the population comes an increase in cancer risk. The nexus of age and cancer is supported by National Cancer Institute (NCI) research. The convergence of an overall aging population and a peak cancer incidence among those aged 65 to 74 will result in a significant rise in the number of people diagnosed with cancer. In addition, as people age the types of treatments and the eligibility and ability for older patients to participate in clinical trials diminishes.

According to the most recent statistical data from NCI’s Surveillance, Epidemiology, and End Results program, the median age of a cancer diagnosis is 66 years. The median age at diagnosis is 61 years for breast cancer, 68 years for colorectal cancer, 70 years for lung cancer, and 66 years for prostate cancer.

Healthcare professionals treating older cancer patients often discover other health conditions that may limit the use of specific therapies. Unless there is sufficient evidence that older patients can benefit from standard dosage of some therapies, clinicians can be reluctant to give older patients potentially beneficial treatments. This practice of less intensive therapy in aging patients is historically understandable; however, a growing field of geriatric oncologists now consider chronological age insufficient evidence for denying aggressive cancer therapy.

The solution to this aging dilemma, like the disease, is complex and we need to better understand how the biological underpinnings of aging affect the onset and trajectory of cancer. Reasons for this increase of cancer with aging can be contributed to the fact that living longer increases our exposure to things that have been shown to be contributing factors in determining cancer risk, such as exposure to sunlight, radiation, environmental toxins and noxious by-products of metabolism that increase with age. “Most aging cells develop genomic changes that make them more susceptible to the carcinogens in the environment,” says oncologist Lodovico Balducci, who studies and treats cancer in the elderly at the Moffitt Cancer Center in Tampa, Fla. In addition, the various immune defenses that keep our tissues healthy begin to break down with age.

Some of the more serious health conditions that are more common in adults over 65 that may impact the response to a cancer diagnosis include; high blood pressure, heart disease, lung disease, diabetes, kidney disease and arthritis. These co-existing conditions must be taken into account when designing cancer treatment protocols for older patients. For those older patients with cancer, knowing how treatments will be affected by these contributing factors is important to understanding how to respond to the process of therapy.

But progress towards better understanding is underway. A joint collaborative effort with the National Institute on Aging (NIA) and the Samuel Waxman Cancer Research Foundation is underway which will promote and support interdisciplinary research projects, sharing of resources, and development of new technologies and approaches to better understand how the physiological changes associated with aging affect cancer development, progression, and response to therapy. NCI is also committing more resources aimed to increase enrollment for older patients in clinical trials.

Cancer Mortality Rates Continue to Decline in The U.S.

GCC Blog Image 2

Continuing a positive trend for the last two decades, cancer death rates declined again last year. According to annual statistics reported from the American Cancer Society, the cancer death rate for men and women combined has fallen 26% from its peak in 1991. This decline translates to nearly 2.4 million deaths averted during this time period.

“Cancer Statistics, 2018,” was published in the American Cancer Society’s journal CA: A Cancer Journal for Clinicians. The information is also available in a companion report, Cancer Facts and Figures 2018, and on a website, the Cancer Statistics Center. Although cancer death rates continue to decline, a total of 1,735,350 new cancer cases and 609,640 deaths from cancer are projected to occur in the US in 2018.

The decline is mostly due to steady reductions in smoking and advances in early detection and treatment. “This new report reiterates where cancer control efforts have worked, particularly the impact of tobacco control,” said Otis W. Brawley, M.D., chief medical officer of the American Cancer Society. “A decline in consumption of cigarettes is credited with being the most important factor in the drop in cancer death rates. Strikingly though, tobacco remains by far the leading cause of cancer deaths today, responsible for nearly 3 in 10 cancer deaths.”

Lung, breast, prostate, and colorectal cancers are leading the way in lower death rates. Lung cancer death rates declined 45% from 1990 to 2015 among men and 19% from 2002 to 2015 among women. Early detection of breast cancer resulted in a 39 percent decline in death rates in women for the same period. Prostate and colorectal cancer experienced a 52 percent reduction between 1970 and 2015, primarily due to increased routine screening.

According to the report, the reduction in death rates is not equal across all ethnic, racial and social economic classes of population. The rates of new cancer occurrence are generally highest among African Americans and lowest for Asian Americans.

Cancer remains the second most common cause of death among children ages 1 to 14 in the U.S. Leukemia accounts for almost a third of all childhood cancers, followed by brain and other nervous system tumors. While child death rates due to cancer have continuously declined since 1975, cancer incidence rates increased in children and adolescents by 0.6% per year for the same period.

The report also reveals that the lifetime probability of being diagnosed with cancer is 39.7% for men and 37.6% for women. The most common cancers to be diagnosed in men are prostate, lung, and colorectal cancers. The most common cancers to be diagnosed in women are breast, lung, and colorectal cancers. Breast cancer accounts for 30% of all new cancer diagnoses in women. Liver cancer incidence continues to increase rapidly in women, but appears to be stabilizing in men.

The good news is particularly rewarding to the professionals at Gettysburg Cancer Center where their understanding of cancer and how to treat it is constantly evolving toward the day when they have a cure. Testing new procedures for identifying and diagnosing certain diseases and conditions, finding ways to prevent certain diseases or conditions before they have a chance to develop, and exploring new methods of supportive care for patients with chronic diseases are at the core of the ongoing clinical trials at the Center.

Early Detection and Treatment May Prevent Cervical Cancer

Cervical Cancer Ribbon

Each year, an estimated 12,820 women in the United States will be diagnosed with some form of cervical cancer. Approximately 4,200 women die from the disease each year, and more than a quarter of a million women will live with the disease each year.  While the numbers can be daunting, when detected early, 91 percent of those diagnosed with cervical cancer will survive.

Long-lasting infections with certain types of human papillomavirus (HPV) cause almost all cases of cervical cancer. Normal cells of the cervix can gradually develop pre-cancerous changes.  These cells do not suddenly change into cancer. Instead, the normal cells of the cervix first gradually develop pre-cancerous changes that may turn into cancer.

The two main types of cervical cancer are squamous cell carcinoma and adenocarcinoma and represent the vast majority of cancer of the cervix. Only some of the women with pre-cancers of the cervix will develop cancer, and it may take several years for cervical pre-cancer to change to cervical cancer. For most women, pre-cancerous cells will go away without any treatment, but others will have their pre-cancers turn into invasive cancers.

Detecting and treating all cervical pre-cancers may prevent true cervical cancers. The Pap test (or Pap smear) and the HPV test may prevent cervical cancer by detecting pre-cancers before they can turn into an invasive form of cancer. During the past several decades, screening has reduced deaths from cervical cancer by finding the cancer early and treating it or preventing it from developing.

For women it can be very hard not to be exposed to HPV. Passed from one person to another during skin-to-skin contact with an infected area of the body, HPV can be spread rapidly and easily.

Available vaccines can protect against infection with the HPV subtypes most commonly linked to cancer. These vaccines help prevent pre-cancers and cancers of the cervix. The vaccines require a series of injections and may cause some mild side effects. The most common are is short-term redness, swelling, and soreness at the injection site.

The American Cancer Society recommends vaccinations for girls and boys beginning at age 11 or 12. HPV vaccination is also recommended for females 13 to 26 and males between the ages of 13 and 21. Vaccination at older ages is less effective in lowering cancer risk. No vaccine provides complete protection against all cancer-causing types of HPV, so routine cervical cancer screening is still recommended.

For more than 25 years, Gettysburg Cancer Center has been committed to providing cancer care in a community-based setting close to home. A leader in Oncology care across the region since 1989, Gettysburg Cancer Center’s cancer team provides screening and treatment options to women across York and Adams County.

For the latest information on early detection and treatments for cervical cancer, contact the Gettysburg Cancer Center.

Finding New Solutions in the Fight Against Cancer Through Research

GCC November Blog Image 1

While the most overt cancer research news usually comes from efforts to derail the progression of the deadly disease, research into the development of alternative pathways to finding an ultimate solution to cancer often go unnoticed or fail to receive the same level of notice among the public. Advances are being made in new techniques to improve the effectiveness of traditional treatment protocols, the utilization of non-traditional or culturally specific treatment methods or identifying dietary or physical behaviors that may lead to increasing or decreasing the risk factors associated with cancer.

An innovative new treatment for an aggressive form of blood cancer has been approved by the U.S. Food and Drug Administration. According to Mounzer Agha, Director of the Mario Lemiuex Center for Blood Cancers at Hillman Cancer Center, the cell based therapy produced a 51 percent remission rate among patients with a strain of lymphoma that didn’t respond well to traditional chemotherapy or radiation. “There was no treatment that could possibly put them into remission, so to get a 50 percent remission rate with this kind of treatment is a major accomplishment,” Agha said. This is a breakthrough for patients and physicians, according to Agha. The treatment is customized to each individual’s immune system. “This type of therapy represents a paradigm shift in the treatment of blood cancer and it will completely change the landscape of how we approach and treat blood cancers in the future,” he said.

In oriental medicine, treatment using acupuncture needles has been commonly practiced for thousands of years in the fields of treating musculoskeletal disorders, pain relief, and addiction relief. Recently, it has emerged as a promising treatment for brain diseases, gastrointestinal disorders, nausea, and vomiting, and studies are under way to use acupuncture to treat severe diseases. A research team lead by Professor Su-Il In, through joint research with Dr. Eunjoo Kim of Companion Diagnostics & Medical Technology Research Group at DGIST and Professor Bong-Hyo Lee’s research team from the College of Oriental Medicine at Daegu Haany University, has published a study showing that the molecular biologic indicators related to anticancer effects are changed only by the treatment of acupuncture. The research was published in the online edition of Scientific Reports, the sister journal of the globally renowned academic journal Nature. Professor Su-Il In said, “This research, which combines nanotechnology and oriental medicine technology, is a scientific study that shows the possibility of using acupuncture as a method to treat severe diseases such as cancer.”

For decades researchers have known that dietary issues can often be a factor in the incidence of cancer. In a paper published in the journal Nature Communications, researchers from VIB, a life sciences research institute, and Vrije University in Brussels found that a compound in sugar stimulates aggressive cancer cells and helps them to grow faster. Led by Johan Thevelein, a microbiologist with VIB, this research builds on what scientists already knew about the Warburg effect, where cancer cells rapidly break down sugar for energy and to fuel for further growth. While the research identifies a link between sugar and the aggressiveness of cancer cells, it doesn’t mean that eliminating sugar from one’s diet will eliminate the likelihood of getting cancer. “We have no evidence of this effect happens in healthy people,” Thevelein says, but “Reducing sugar intake during cancer treatment might help the system to overcome the cancer and it might facilitate the action of chemotherapy because it’s difficult to kill the cancer cells if they’re always activated [by sugar],” he says. “Providing sugar to cancer cells carries a greater risk of stimulating their aggressiveness.”

In Queensland, Australia scientist Georgia Chenevix-Trench has uncovered an additional 72 genetic markers that can indicate an increased likelihood that a patient may be more susceptible to getting cancer in their lifetime.  The discovery may lead to the development of a more definitive predictive test for breast cancer in women.

While most of us hope for quick and all-encompassing cure for cancer, the complexity and the infinite variety of cancer types indicate that a single solution is more than unlikely. The ultimate solutions will come from a combination a multitude of treatments and advances in early prediction and detection.

Gettysburg Cancer Center is actively involved with a consortium of doctors offering clinical trials for patients seeking alternative solutions and therapies.  For more information on the current clinical trials available, visit http://gettysburgcancercenter.com/patients/clinical-trials/.

Gene Therapy. A New Frontier in Medical Innovation

GCC Blog Image 2 (800x450)

Cancer is a disease that is experienced by young and old and by every economic and social segment of the world populace. At some point in everyone’s life, cancer will affect us individually, a member of our family or one or many of our friends and acquaintances. The American Cancer Society projects there will be 1,688,780 new cancer patients and 600,920 deaths due to cancer in 2017, for a disease that does not discriminate by race or national origin.

Cancer is where abnormal cell growths form in the body and interfere with normal, healthy body functions. Not new to the world stage, cancer dates back to ancient times. Today, after millennials of research and discovery, new treatments for a vast array of cancer types are being studied, many with promising results.  One such new treatment called chimeric antigen receptor T-cell therapy (CAR-T) involves taking samples of T-immune cells called T-cells from a patient, genetically engineering them, and putting them back in to fight the cancer. Co-developed with the drug giant Novartis, the therapy, CAR-T, genetically alters a patient’s own immune cells to target and destroy cancer cells.

“We’re entering a new frontier in medical innovation with the ability to reprogram a patient’s own cells to attack a deadly cancer,” said FDA Commissioner Dr. Scott Gottlieb. The process takes about 22 days and begins with the extraction of a patients T cells, exposing them to the vector which genetically transforms them. They’re then expanded and frozen for shipment back to the patient. During the out-of-body processing of the cells, the patient receives chemotherapy to wipe out any remaining T cells to avoid interference with the, soon to be, newly implanted cells.

“This is a major advance, and is ushering in a new era,” said Malcolm Smith, a pediatric oncologist at the National Institutes of Health. The treatment appears to strengthen a patient’s immune system allowing their own body to fight the cancer. The treatment is recommended for cancer patients who have run out of options for traditional therapy. The new therapy is only currently available for patients 25 years or younger. Thus far, 83 percent of patients are experiencing positive survival results.

While overtly touting the success of gene therapy, researchers are tempering their enthusiasm after experiencing some significant life threatening side effects in 47 percent of the studies participants. These side effects have resulted in brain swelling and deaths, casting a shadow over the field. Seizures and hallucinations were also relatively common, but temporary. Though concerning, the side effects have been successfully managed with drugs. Quality control and how to standardize the potency and purity of living cells extracted from each patient are also a concern. Because of the risks, the treatment is only currently available at 20 US hospitals. The individualized nature and relatively small patient population both drive up the cost of the treatment for now.

“This is a big paradigm shift, using this living drug,” says Dr. Kevin Curran, a pediatric oncologist at Memorial Sloan Kettering Cancer Center that will soon be offering the treatment. “It will provide a lot of hope. This is the beginning.”

“The approval of CAR T-cell therapy for pediatric leukemia marks an important shift in the blood cancer treatment paradigm,” says the American Society of Hematology. “We now have proof that it is possible to eradicate cancer by harnessing the power of a patient’s own immune system. This is a potentially curative therapy in patients whose leukemia is unresponsive to other treatments and represents the latest milestone in the shift away from chemotherapy toward precision medicine. Today’s approval is the result of over a decade of hematology research, including research funded by the National Institutions of Health (NIH).”

The Best in Cancer Care Across the Community

September Blog 2 Image

Healthcare and access to quality healthcare is a critical issue for individuals whether healthy or recently diagnosed with a life-threatening illness.  Most patients have experienced a private medical practice being merged into a large healthcare system and often don’t understand how that will impact their care.

While large specialized health centers can promise to offer the most advanced techniques, facilities and methods, they are usually located in large urban centers, often miles and driving hours from the patient’s home, requiring long and physically taxing commutes for frequent treatments. Although staffed with caring and competent professionals these mega centers can often feel overly clinical and crowded, giving the patient a sense of being just another number among many.

The best and most advanced treatment and care is becoming less centralized, allowing for advanced specialized care to be available within the patient’s own community, providing ease of care access and reducing the personal stresses often accompanying cancer therapy.

Gettysburg Cancer Center (GCC) has been a leader in Oncology Care in the Adams County region since 1989. For more than 25 years, the highly regarded and vastly experienced medical specialists have been committed to providing cancer care in a community-based setting close to their patient’s home. The all-encompassing oncology and hematology programs provide a complete range of diagnosis, treatment, and follow-up care in an environment that recognizes the importance of treating not only the disease but the individual person behind the disease.

With Medical Oncology, Radiation Oncology, Diagnostic Imaging, access to the latest clinical trials as well as an onsite laboratory and pharmacy, Gettysburg Cancer Center truly offers comprehensive cancer care. Their compassionate and experienced staff takes pride in providing the best possible care and personal assistance to their patients and their patient’s families. Dr. Satish Shah, Principle Medical Oncologist and Hematologist at GCC says, “Our mission is to provide individualized treatment, utilizing the best technical approach.  We focus on providing the best treatment in the right environment so that our patients can focus on getting better.”

To learn more about how GCC’s is helping their cancer patients, click on http://gettysburgcancercenter.com/about-us/testimonials/.

Cancer Diagnosis: A Second Opinion Can Often Lead to the Best Treatment Plan

Most of us would not consider making a major modification to our home without consulting a number of professionals or contractors. After all, getting more than one perspective on the scope of work can reveal a clear understanding of the costs, the potential inconveniences of the process, better prepare for the complexities of the work and more clearly define our expectations. Few of us would argue against the benefits of investing the time and patience in getting a second opinion.

Research shows that half of the patients diagnosed with serious illnesses such as cancer, never seek a second opinion before embarking on a series of treatments for a sometimes life threatening disease. The data reflects that only three percent considered a second opinion to be essential before accepting a diagnosis or course of action. Considering complexities of cancer and the importance of selecting the right course of action for each specific type, it is not just a good idea to initiate a second opinion, it is imperative to understanding all your options and establishing confidence in your final decision. Such important health decisions should be made only after you have learned all you can about your diagnosis, prognosis, available and treatment options.

Several reasons why so many fail to seek a second opinion can be easily explained. A cancer diagnosis is scary; and many patients feel a need to act immediately on a course of treatment to have the best chance of survival. But while in some cases taking immediate action is imperative, most cancer patients have time to learn all there is about their disease before setting out on the treatment journey. Others feel a sense of unquestioned confidence in their personal physician’s ability to diagnose and treat their condition. They often feel that questioning their results could be seen as an insult to their doctor.

Medicine is not an exact science. Even new advancements in treatment options, even the most dedicated and conscientious of practitioners cannot be expected to have the latest science at their fingertips. Many doctors are not only very comfortable with their patients seeking a second opinion, most routinely recommend the action. The results of  “a 2006 study found that when breast cancer patients came to a specialty center for a second opinion, recommendations for surgery changed for more than half, a result of different interpretations and readings of mammograms and biopsy results.”

After Greg Walde received an initial oncology evaluation and treatment at a local oncology center in Gettysburg, Pennsylvania he was told, that due to the advanced stage of his disease, he had little time to live. He was informed that there simply were no effective treatment options for his advanced stage of cancer. The disease, he was informed, had just progressed too far. “At that point,” Greg says, “I went home, very down about things”. After several weeks of distress and depression over his situation he decided to seek another opinion at The Gettysburg Cancer Center just down the street from where he had previously received the bad news. In Greg’s case the value of a second opinion included new treatment options and more time at living his life.

When faced with a cancer diagnosis it becomes critical to find the right oncology center with the experience and dedication to provide the latest and most appropriate medical treatment and support available to fight the battle. At his Gettysburg Cancer Center in Gettysburg, PA, Dr. Satish Shah, Medical Oncologist/Hematologist says, “We understand that every person is unique. Our team is dedicated to providing the latest approaches to treatment in a caring environment for patients and their families to insure the best possible outcome for their cancer treatment.”

For more information on the Gettysburg Cancer Center, visit www.gettysburgcancercenter.com.

“No One Fights Alone”

Receiving a cancer diagnosis is a shocking experience even for those in more advanced life stages. It is a situation that most of us fear at some point in our lives. However, for those that receive a diagnosis at an early age when transitioning from adolescents to young adulthood, the ability to cope and process the significance of the news must be particularly challenging.

As a teenager in 2015, Chandler Banko’s was diagnosed with advanced, stage 2 Hodgkin’s Lymphoma. An athletic and seemingly healthy seventeen year old, Chandler’s news that he had cancer wasn’t made any easier to understand by knowing that the most common age of diagnosis of this cancer is between 20 and 40 years of age.

Hodgkin lymphoma, also known as Hodgkin’s disease, is a type of cancer affecting the lymphatic system which occurs “when the lymph node cells or the lymphocytes begin to multiply uncontrollably, producing malignant cells that have the abnormal ability to invade other tissues throughout the body.” Generally more common in males than females, the exact cause of Hodgkin lymphoma is not known. Nearly 574,000 people reported having the cancer in 2015, a disease which presents in about 2 percent of the Nation’s population. Because of progress in treating Hodgkin lymphoma, most people with a diagnosis of Hodgkin lymphoma will be long-time survivors. For those under twenty, the survival rate is 97 percent.

A positive and outgoing personality, Chandler found help and treatment at the Gettysburg Cancer Center in Gettysburg, Pennsylvania. There he found experienced professionals who are dedicated to treating not only the science of his disease but the personal emotional conditions that often accompany a cancer diagnosis and regiment of treatment. “My experience with GCC was way beyond my expectations” Chandler says in his testimonial video. “They never failed to support me and made sure I kept fighting”.

Chandler, his family and friends established a trust fund for the purpose of paying his unreimbursed medical expenses as well as support for education expenses. A student at nearby Mount Saint Mary’s University in Emmittsburg, Maryland, Chandler is active as a personality at the Universities WMTB Mount Radio as he pursues a degree in Cyber Security and Business. All while holding down a job at a local sports apparel shop.

Recently the “Ladies” at Gettysburg Cancer Center gifted him a bunch of balloons in celebration of his 20th birthday. They all surprised him during a follow-up appointment by singing Happy Birthday. “Love these people!!!” said Chandler.

Looking back on his fight to survive his cancer, Chandler speaks of his experience. “If I had one thing to take away from this past year, it’s to never turn back and keep looking forward. To everyone who walked with me, fought with me, prayed for me and supported me, thank you. Today, I am officially done with everything pertaining to my fight. I completed my final surgery and I am proud to say: I am clear, I am healthy and I am moving on. I can now focus on living my life and enjoying everything it gives me. Life can be short, life can throw you around…. but it all depends on how you take those negatives, and build yourself up.”

Finding the Emotional Support You Need to Recover From Cancer

March Blog 1 Image

The discovery that you have cancer comes with many intense emotions, not only for the patient but also for close family members and friends. After the initial emotional and psychological effects of the news subsides, there is a realization that everything in your life is about to change. Daily routines, family roles and future plans will be determined by a regiment of treatments and medications that often pose additional physical symptoms and challenges to everyday living.

The support of family and friends during this process is critical to help the patient regain a sense of normalcy and maintain emotional stability. Efforts such as pier group support and individual therapy can help reduce distress and help cope with the personal emotions that come with a cancer diagnosis. Such support can play a critical role in determining the your clinical outcome.

Musa Mayer, a cancer survivor and patient advocate says, “Belonging to a group where you can discuss anything and everything is very freeing. You can talk about everything from medical treatments to lack of sexual interest, to fury at someone who has cut you off while driving. The loneliness and isolation that so many feel when they are going through the breast cancer journey can be helped, if not erased.”

Your doctor and their professional associates and nursing staff will also play a central role in providing coordination and support during treatment and recovery. “We have to look at a person’s medical care from a holistic perspective,” says Terri Ades, MS, APRN-BC, AOCN, director of cancer information at the American Cancer Society in Atlanta. Nurses are a patient’s greatest advocate.” Whether an oncology nurse or a nurse practitioner, these specially trained medical professionals become an important facilitator in managing overall care.

At his Gettysburg Cancer Center in Gettysburg, PA, Dr. Satish Shah, Medical Oncologist/Hematologist provides all-encompassing oncology and hematology programs with a complete range of diagnosis, treatment, and follow-up care. “It is our educated staff that set us apart from many other cancer centers,” says Dr. Shah, “We understand that every person is unique, each with their own set of psychological, emotional, and spiritual needs. Our team is dedicated to providing a caring environment for each individual patient and their families to insure the best possible outcome for their cancer treatment.”

In addition to your professional caregivers, The American Cancer Society has programs and services to help people with cancer and their loved ones understand cancer, manage their lives through treatment and recovery, and find the emotional support you need.